Literature DB >> 3511535

Human megakaryocytopoiesis.

A M Gewirtz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3511535

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  7 in total

1.  Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response.

Authors:  Marco Pizzi; Richard T Silver; Ariella Barel; Attilio Orazi
Journal:  Mod Pathol       Date:  2015-08-14       Impact factor: 7.842

2.  Isolation of a src homology 2-containing tyrosine phosphatase.

Authors:  J Plutzky; B G Neel; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 3.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Distinct functional effects for dynamin 3 during megakaryocytopoiesis.

Authors:  Wenjing Wang; Diana M Gilligan; Sijie Sun; Xiaoping Wu; Jo-Anna Reems
Journal:  Stem Cells Dev       Date:  2011-08-04       Impact factor: 3.272

5.  Diploid and tetraploid precursors of megakaryocytes in normal human bone marrow detected by immunofluorescence.

Authors:  D Renner; H Propp; W Queisser
Journal:  Blut       Date:  1987-11

Review 6.  Significance of polyploidy in megakaryocytes and other cells in health and tumor disease.

Authors:  M Winkelmann; P Pfitzer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-12-01

7.  Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

Authors:  A M Gewirtz; B Calabretta; B Rucinski; S Niewiarowski; W Y Xu
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.